Bone formation is impaired in MM patients, and the abnormal IGFBP profile demonstrated here in the local BM microenvironment, could play a role in deregulation of bone remodeling in MM patients, since IGFBP-2 is known to be involved in bone formation and density determination [23]. The gene discussed is IGFBP2; the disease is Miyoshi myopathy.